Andrew J Yee

29PUBLICATIONS
86CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersMedical anthropology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Apr 28, 2026
Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: insights from a multicenter case series.

|Apr 22, 2026
Validation and refinement of the new Consensus Genomic Staging (CGS) of high-risk multiple myeloma (HRMM) in relapsed and refractory patients treated with BCMA CAR-T.

|Apr 08, 2026
Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study.

Omar Nadeem, Michelle P Aranha, Robert A Redd

|Jan 27, 2026
Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea.

Viktoria Blumenberg, Filippo Birocchi, Angela Shih

|Dec 19, 2025
Prognostic value of serological and PET/CT response kinetics in patients with multiple myeloma treated with BCMA CAR-T.

Joshua N Gustine, John A Scaringi, Fabian Bauer

|Oct 22, 2025
Case 30-2025: An 82-Year-Old Woman with Abdominal Distention, Edema, and Pleural Effusion.

Zahir Kanjee, Cynthia L Czawlytko, Pui W Cheung

Pageof 5

Frequent Collaborators

11 joint publications

Andrew R Branagan

5 joint publications

Diana D Cirstea

4 joint publications

Marcela V Maus

4 joint publications

Jacob P Laubach